A new proof-of-concept method reliably engineered a hotspot mutation of SF3B1, a gene-splicing gene, into diverse cancer cell lines, outperforming other contemporary editing approaches.

Genetic analysis | Image Credit: © angellodeco - stock.adobe.com

Review: CAR T Cells Could Transform Pediatric SLE Therapy

By Jared Kaltwasser

September 4th 2024

Early data suggest chimeric antigen receptor (CAR) T-cell therapy can achieve meaningful long-term results.

CAR T-cell therapy has revolutionized cancer treatment | image credit: Serhii - stock.adobe.com

Neurological Complications in CAR T-Cell Therapy: A Case of Parkinsonism

By Kimberly Rath, PharmD

September 4th 2024

A case report highlights a rare instance of parkinsonism following CAR T-cell therapy for multiple myeloma.

Looking to CAR T-Cell Therapy in Refractory Pediatric SLE

By Gayle Turim Dickstein

August 28th 2024

Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE).

Gene therapy trials | Image Credit: ArtemisDiana-stock.adobe.com

An Updated Snapshot of Gene Therapy Clinical Trials Worldwide

By Gayle Turim Dickstein

August 23rd 2024

The gene therapy landscape has changed dramatically in the past 5 years, and investigators wanted to capture and analyze the details of current and upcoming trials, along with their potential impact on patients.

<1 2 3

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions